Annual Operating Profit
-$214.05 M
-$84.91 M-65.75%
December 31, 2023
Summary
- As of February 8, 2025, XENE annual operating income is -$214.05 million, with the most recent change of -$84.91 million (-65.75%) on December 31, 2023.
- During the last 3 years, XENE annual operating profit has fallen by -$182.75 million (-583.86%).
- XENE annual operating profit is now -2027.37% below its all-time high of $11.11 million, reached on December 31, 2014.
Performance
XENE Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$73.68 M
-$4.57 M-6.62%
September 30, 2024
Summary
- As of February 8, 2025, XENE quarterly operating income is -$73.68 million, with the most recent change of -$4.57 million (-6.62%) on September 30, 2024.
- Over the past year, XENE quarterly operating profit has dropped by -$4.57 million (-6.62%).
- XENE quarterly operating profit is now -950.66% below its all-time high of $8.66 million, reached on September 30, 2014.
Performance
XENE Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$255.52 M
-$17.99 M-7.57%
September 30, 2024
Summary
- As of February 8, 2025, XENE TTM operating income is -$255.52 million, with the most recent change of -$17.99 million (-7.57%) on September 30, 2024.
- Over the past year, XENE TTM operating profit has dropped by -$17.99 million (-7.57%).
- XENE TTM operating profit is now -2051.99% below its all-time high of $13.09 million, reached on September 30, 2014.
Performance
XENE TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
XENE Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -65.8% | -6.6% | -7.6% |
| 3 y3 years | -583.9% | -32.5% | -37.3% |
| 5 y5 years | -462.7% | -32.5% | -37.3% |
XENE Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -171.0% | at low | -324.2% | at low | -223.5% | at low |
| 5 y | 5-year | -583.9% | at low | <-9999.0% | at low | -774.2% | at low |
| alltime | all time | -2027.4% | at low | -950.7% | at low | -2052.0% | at low |
Xenon Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$73.68 M(+6.6%) | -$255.52 M(+7.6%) |
| Jun 2024 | - | -$69.10 M(+17.0%) | -$237.52 M(+6.0%) |
| Mar 2024 | - | -$59.04 M(+10.0%) | -$224.04 M(+4.7%) |
| Dec 2023 | -$214.05 M(+65.7%) | -$53.70 M(-3.6%) | -$214.05 M(+5.1%) |
| Sep 2023 | - | -$55.68 M(+0.1%) | -$203.69 M(+9.4%) |
| Jun 2023 | - | -$55.62 M(+13.4%) | -$186.13 M(+15.7%) |
| Mar 2023 | - | -$49.05 M(+13.2%) | -$160.82 M(+24.5%) |
| Dec 2022 | -$129.14 M(+63.5%) | -$43.33 M(+13.6%) | -$129.14 M(+16.7%) |
| Sep 2022 | - | -$38.13 M(+25.8%) | -$110.65 M(+25.6%) |
| Jun 2022 | - | -$30.32 M(+74.5%) | -$88.12 M(+9.7%) |
| Mar 2022 | - | -$17.37 M(-30.1%) | -$80.30 M(+1.7%) |
| Dec 2021 | -$78.99 M(+152.4%) | -$24.84 M(+59.2%) | -$78.99 M(+17.8%) |
| Sep 2021 | - | -$15.60 M(-30.7%) | -$67.08 M(+9.6%) |
| Jun 2021 | - | -$22.50 M(+40.1%) | -$61.18 M(+55.6%) |
| Mar 2021 | - | -$16.06 M(+24.3%) | -$39.33 M(+25.6%) |
| Dec 2020 | -$31.30 M(-26.9%) | -$12.92 M(+33.2%) | -$31.30 M(+4.4%) |
| Sep 2020 | - | -$9.70 M(+1401.4%) | -$29.98 M(+2.6%) |
| Jun 2020 | - | -$646.00 K(-92.0%) | -$29.23 M(-25.2%) |
| Mar 2020 | - | -$8.03 M(-30.7%) | -$39.09 M(-8.7%) |
| Dec 2019 | -$42.82 M(+12.6%) | -$11.60 M(+29.6%) | -$42.82 M(+7.9%) |
| Sep 2019 | - | -$8.95 M(-14.8%) | -$39.67 M(-11.7%) |
| Jun 2019 | - | -$10.51 M(-10.6%) | -$44.91 M(+6.9%) |
| Mar 2019 | - | -$11.76 M(+39.1%) | -$41.99 M(+10.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$38.04 M(+16.8%) | -$8.45 M(-40.4%) | -$38.04 M(+1.1%) |
| Sep 2018 | - | -$14.19 M(+86.8%) | -$37.64 M(+17.3%) |
| Jun 2018 | - | -$7.59 M(-2.7%) | -$32.09 M(-0.9%) |
| Mar 2018 | - | -$7.81 M(-3.0%) | -$32.39 M(-0.6%) |
| Dec 2017 | -$32.58 M(+31.3%) | -$8.05 M(-6.9%) | -$32.58 M(+8.6%) |
| Sep 2017 | - | -$8.64 M(+9.5%) | -$29.99 M(+4.6%) |
| Jun 2017 | - | -$7.89 M(-1.2%) | -$28.67 M(+5.6%) |
| Mar 2017 | - | -$7.99 M(+46.2%) | -$27.15 M(+9.4%) |
| Dec 2016 | -$24.82 M(+165.1%) | -$5.46 M(-25.5%) | -$24.82 M(+13.0%) |
| Sep 2016 | - | -$7.33 M(+15.2%) | -$21.96 M(+42.2%) |
| Jun 2016 | - | -$6.37 M(+12.5%) | -$15.45 M(+73.9%) |
| Mar 2016 | - | -$5.66 M(+117.4%) | -$8.88 M(-5.1%) |
| Dec 2015 | -$9.36 M(-184.3%) | -$2.60 M(+217.4%) | -$9.36 M(+39.2%) |
| Sep 2015 | - | -$820.00 K(-512.1%) | -$6.72 M(-343.8%) |
| Jun 2015 | - | $199.00 K(-103.2%) | $2.76 M(-29.9%) |
| Mar 2015 | - | -$6.14 M(<-9900.0%) | $3.94 M(-64.6%) |
| Dec 2014 | $11.11 M(+14.4%) | $35.00 K(-99.6%) | $11.11 M(-15.2%) |
| Sep 2014 | - | $8.66 M(+528.5%) | $13.09 M(+19.6%) |
| Jun 2014 | - | $1.38 M(+33.5%) | $10.95 M(+14.4%) |
| Mar 2014 | - | $1.03 M(-48.9%) | $9.57 M(+12.1%) |
| Dec 2013 | $9.71 M(-408.0%) | $2.02 M(-69.0%) | $8.54 M(+31.0%) |
| Sep 2013 | - | $6.52 M | $6.52 M |
| Dec 2012 | -$3.15 M(-74.0%) | - | - |
| Dec 2011 | -$12.11 M | - | - |
FAQ
- What is Xenon Pharmaceuticals annual operating income?
- What is the all time high annual operating profit for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals annual operating profit year-on-year change?
- What is Xenon Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals quarterly operating profit year-on-year change?
- What is Xenon Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals TTM operating profit year-on-year change?
What is Xenon Pharmaceuticals annual operating income?
The current annual operating profit of XENE is -$214.05 M
What is the all time high annual operating profit for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high annual operating income is $11.11 M
What is Xenon Pharmaceuticals annual operating profit year-on-year change?
Over the past year, XENE annual operating income has changed by -$84.91 M (-65.75%)
What is Xenon Pharmaceuticals quarterly operating income?
The current quarterly operating profit of XENE is -$73.68 M
What is the all time high quarterly operating profit for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high quarterly operating income is $8.66 M
What is Xenon Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, XENE quarterly operating income has changed by -$4.57 M (-6.62%)
What is Xenon Pharmaceuticals TTM operating income?
The current TTM operating profit of XENE is -$255.52 M
What is the all time high TTM operating profit for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high TTM operating income is $13.09 M
What is Xenon Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, XENE TTM operating income has changed by -$17.99 M (-7.57%)